NCT05714826 Comprehensive Optimization At-time of Radical Cystectomy Intervention
| NCT ID | NCT05714826 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | Bladder Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 194 participants |
| Start Date | 2024-04-25 |
| Primary Completion | 2026-05-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 194 participants in total. It began in 2024-04-25 with a primary completion date of 2026-05-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study is aimed at a comprehensive optimization at-time of radical cystectomy (COARC) intervention that focuses on patient optimization throughout the perioperative continuum, from the pre-operative setting to the post-operative period, among patients undergoing radical cystectomy for bladder cancer. This multi-modal strategy will focus on three phases of care around surgery: the pre-operative, peri-operative, and post-operative phases. The intervention group will focus on multiple areas of patient optimization including remote patient monitoring for the earlier identification of potential complications. The overall study mission is to decrease complication rates after radical cystectomy using this comprehensive approach.
Eligibility Criteria
Inclusion Criteria: * Adults equal to or more than 18 years old * Diagnosis of bladder cancer with plan to undergo radical cystectomy * Agrees to participate in study procedures Exclusion Criteria: * Patients undergoing cystectomy for diagnosis other than bladder cancer * Do not provide informed consent
Contact & Investigator
Yair Lotan, MD
PRINCIPAL INVESTIGATOR
University of Texas Southwestern Medical Center
Frequently Asked Questions
Who can join the NCT05714826 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05714826 currently recruiting?
Yes, NCT05714826 is actively recruiting participants. Contact the research team at Jacob.Taylor@UTSouthwestern.edu for enrollment information.
Where is the NCT05714826 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT05714826 clinical trial?
NCT05714826 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Yair Lotan, MD at University of Texas Southwestern Medical Center. The trial plans to enroll 194 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.